SarcomaBCB data dictionary

Patient (15 items)

Centre (ConticaBase)

Type : Constrained
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : No

Description : Centre ConticaBase

Possible values :
Lyon CLB, Hôp Pasteur, Cy-Path, Hôp. Charles Nicolle, Hôp. Gabriel Montpied, Hôp. Pontchaillou, CHU Rouen, Institut d'histopathologie de Nantes, CHU Amiens, CHRU De Dijon, Labo. de Limoges, Labo. des Feuillants, Centre Patho Dijon, Centre Patho de Metz, Cabinet Mathurin, Cabinet d’Amiens, Cabinet de Reims, Cabinet de Rennes, Service d'anapath de Brest, Cabinet de la Roquette, Cabinet de Douai, Villejuif IGR, Milan INT, Padova UNIPD, KLEUVEN, CHRU Lille, Saint-Louis, Bergonié, Curie, Mannheim, Nice CAL, Dijon CGFL, Caen CFB, Marseille IPC, Nancy ICL, Lille COL, Lausanne, Montpellier ICM, Angers ICO, Nantes ICO , IUCT Toulouse, Strasbourg CHU, Bruxelles, CJP, Paris Henri Mondor, Warsaw Cancer Center, Timone, Cochin, Rennes CEM, Heidelberg, Bonn, Haut-Lévèque Bordeaux, Tübingen, LUMC, Ambroise Paré APHP, Nantes CHU, Tours Trousseau, CPS Strasbourg, CHRU Montpellier, Limoges Dupuytren, Rouen CHB, Lyon IHOP, St Etienne ICLN, Reims IJG, Besançon CHU, Reims CHU, La Réunion CHU, Tenon, Bicêtre, Pitié Salpétrière, GHSN - LYON, Hôp. Civil Strasbourg, CHRU Caen, CHRU Brest, CHU Nancy, Rangueil Toulouse, Purpan Toulouse, Centre Hospitalier - Lille, CHRU Angers, Hôp. Nord Marseille, MEDIPATH, APHP Bichat, APHP Saint-Antoine, Bordeaux Pellegrin, Lyon Edouard Herriot, CHR ORLEANS, Nice CHU, Cabinet Bièvres, Atalante Pathologique

File number

Type : Free value
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : Yes

Description : The unique file number the patient has in his centre

Birth date

Type : Free value
Content : DATE
Mandatory : Yes
Multiple values : No
Unique : No

Description : The patient's birth date

Sex

Type : Constrained
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : No

Description : The patient's gender

Possible values :
Female, Male

Creation date patient

Type : Free value
Content : DATE
Mandatory : Yes
Multiple values : No
Unique : No

Description : The date when the patient has been created in the database

Significant previous history

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description : No: no significant previous historyNF1: presence of neurofibromatosis type 1 or Recklinghausen diseaseNF2: presence of neurofibromatosis type 2Radiation therapy: tumour developed in a previously radiated areaLymphoedema: tumour developed on a preexisting lymphoedemaGardner: presence of a Gardner syndromLi Fraumeni: presence of a Li Fraumeni diseasePrevious cancer: the patient has previously developed another cancer different from the current tumourOther: other significant previous history with a possible link with the current tumour

Possible values :
No, Previous cancer, NF1, NF2, Gardner syndrome, Li Fraumeni syndrome, Retinoblastoma syndrome, Immunodepressed - HIV, Immunodepressed - other, Ollier disease, Maffucci syndrome, Paget disease, Multiple osteochondromas, McCune-Albright syndrome, Rothmund-Thomson syndrome, Werner syndrome, Cherubism, Other genetic disease, Other, Unknown, Familial GISTs, Stratiakis-Carney dyad, Carney Triad, Other malignancy in family

Significant previous history detail

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Other cancer

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Has the patient another cancer

Possible values :
Yes, No, Unknown

Date of last contact

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description : Date of the last follow up evaluation or date of death

Lost of follow-up

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Lost of follow-up

Possible values :
No, Yes

Vital status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Vital status at last contact

Possible values :
Alive, Dead

Cause of death

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Cause of death

Possible values :
- Dead of this cancer
- Primary cancer
- Metastatic disease
- Dead of other cancer
- Dead of treatment complication
- Dead of other cause
- Unknown

Date of death

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

Quality control Conticabase

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Yes

Date of control

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

Primary tumour (57 items)

Type of tumour

Type : Constrained
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : No

Description : point de départ du développement de la tumeur

Possible values :
Soft tissue, Viscera, Bone

Site of tumour

Type : Constrained
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : No

Description : Site of tumour according to the scroll menu

Possible values :
- Soft tissue
- Head and neck
- Superficial areas of head
- Sinus and nasal fossa
- Deep facial areas
- Orbit
- Anterior skull base
- Ear - lateral skull base and nasoharynx
- Oral cavity - oropharynx
- Visceral space of the neck
- Neck NOS
- Other
- Trunk wall
- Chest wall
- Axilla
- Abdominal wall
- Trunk - paraspinal
- Buttock
- Groin
- Internal trunk
- Retroperitoneum
- Peritoneum
- Pelvis
- Thorax internal
- Large vessels
- Paratesticular
- Lower limb
- Thigh
- Knee
- Leg
- Ankle
- Foot
- Toe
- Upper limb
- Shoulder girdle
- Upper arm
- Elbow
- Forearm
- Wrist
- Hand
- Finger
- Viscera
- Gastro Intestinal tractus
- Oesophagus
- Stomach
- Duodenum
- Appendix
- Small intestine
- Colon
- Rectum
- Anus
- Gyneacological area
- Uterus
- Ovary
- Fallopian tube
- Vagina
- Vulva
- Others
- Breast
- Lung
- Heart
- Pleura
- Thymus
- Thyroid
- Kidney
- Bladder
- Ureter
- Prostate
- Testis
- Epididymis
- Penis
- Spleen
- Liver
- Pancreas
- Gallbladder
- Salivary gland
- Tonsil
- Adrenal
- Brain
- Meninges
- Lymph node
- Bone
- Skull and face bone
- Skull NOS
- Ethmoid
- Superior maxilla
- Mandible
- Bone face
- Upper airways
- Larynx
- Bronchus
- Nasal septum
- Spine
- Cervical spine
- Dorsal spine
- Lumbar spine
- Basin, sacrum, coccyx
- Basin
- Sacrum
- Coccyx
- Hip joint
- Other thoracic bone
- Rib
- Sternum
- Clavicle
- Superior limb and shoulder
- Bone shoulder girdle
- Scapula
- Shoulder joint
- Humerus
- Elbow joint
- Ulna
- Radius
- Wirst joint
- Hand bone NOS
- Carpal (Hand)
- Metacarpals (Hand)
- Hand phalanges
- Hand joint
- Inferior limb
- Femur
- Patella
- Knee joint
- Tibia
- Fibula
- Ankle joint
- Bone foot NOS
- Tarsals (Foot)
- Metatarsals (Foot)
- Foot phalanges
- Foot joint

Side (RESOS)

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Laterality of bone tumour in human body

Possible values :
Left, Right, Median, Unspecified, Not applicable

Size of tumour (mm)

Type : Free value
Content : DECIMAL
Mandatory : No
Multiple values : No
Unique : No

Description : Largest diameter of the tumour expressed in mm

Depth of tumour

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Superficial: the tumour is located above the superficial aponeurosis with no involvement of this aponeurosis Deep: the tumour is located beneath the superficial aponeurosis with no involvement of the area above this aponeurosis. Involvement of the aponeurosis is possibleSuperficial and deep: the tumour is located above and beneath the superficial aponeurosis

Possible values :
Superficial, Superficial and deep, Deep, Surface, Cortical, Intra-medullary

Histotype

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Histotype of the primary tumour to be chosen in the scroll menu (2013 WHO classification, 0)

Possible values :
- Benign lesion
- Benign adipocytic tumours
- Angiolipoma
- Angiomyolipoma
- Chondroid lipoma
- Hibernoma
- Lipoblastoma/lipoblastomatosis
- Lipoma
- Lipomatosis
- Lipomatosis of nerve
- Myelolipoma
- Myolipoma
- Spindle cell / pleomorphic lipoma
- Benign chondrogenic tumours
- Chondroma
- Enchondroma
- Osteochondroma
- Osteochondromyxoma
- Periosteal chondroma
- Subungueal exostosis
- Synovial chondromatosis
- Benign fibroblastic/myofibroblastic tumours
- Adenofibroma
- Angiofibroma
- Angiomyofibroblastoma
- Calcifying aponeurotic fibroma
- Calcifying fibrous tumour
- Cellular angiofibroma
- Desmoplastic fibroblastoma
- Elastofibroma
- Fasciitis
- Fibro-osseous pseudotumour of digits
- Fibroma of tendon sheath
- Fibromatosis colli
- Fibrous hamartoma of infancy
- Gardner fibroma
- Inclusion body fibromatosis
- Intra-nodal palisaded myofibroblastoma
- Ischaemic fasciitis
- Juvenile hyaline fibromatosis
- Mammary-type myofibroblastoma
- Myositis ossificans
- Nasopharyngeal angiofibroma
- Nodular fasciitis
- Nuchal-type fibroma
- Organ-associated pseudosarcomatous myofibroblastic proliferations
- Other fibromas
- Proliferative fasciitis
- Proliferative myositis
- Benign fibro-histiocytic tumours
- Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws)
- Deep benign fibrous histiocytoma
- Fibrous histiocytoma
- Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma)
- Non Ossifying fibroma
- Tenosynovial giant cell tumour
- Tenosynovial giant cell tumour, diffuse type
- Tenosynovial giant cell tumour, localized type
- Benign nerve sheath tumours
- Benign Triton tumour
- Dermal nerve sheath myxoma
- Ectopic meningioma
- Granular cell tumour
- Hybrid nerve sheath tumours
- Melanotic schwannoma
- Nasal glial heterotopia
- Neurofibroma
- Neurothekeoma
- Perineurioma
- Plexiform neurofibroma
- Schwannoma
- Solitary circumscribed neuroma
- Benign notochordal tumour
- Benign osteogenic tumours
- Osteoid osteoma
- Osteoma
- Benign pericytic tumours
- Angioleiomyoma
- Glomus tumour
- Myofibroma / myofibromatosis
- Myopericytoma
- Benign skeletal muscle tumours
- Rhabdomyoma
- Rhabdomyoma - adult type
- Rhabdomyoma - fetal type
- Rhabdomyoma - genital type
- Benign smooth muscle tumours
- Atypical polypoid adenomyoma
- Bizarre nuclei leiomyoma
- Cellular leiomyoma
- Diffuse leiomyomatosis
- Dissecans leiomyoma
- Epithelioid leiomyoma
- Intraveinous leiomyomatosis
- Leiomyoma
- Leiomyomatosis peritonealis disseminata
- Mitotically-active leiomyoma
- Myxoid leiomyoma
- Benign tumours of uncertain differentiation
- Acral fibromyxoma
- Brown tumour
- Deep (aggressive) angiomyxoma
- Ectopic hamartomatous thymoma
- Fibrous dysplasia
- Inflammatory fibroid polyp
- Intramuscular myxoma
- Juxta-articular myxoma
- Osteofibrous dysplasia
- Pleomorphic hyalinizing angiectatic tumour
- Rosai-Dorfman disease
- Simple bone cyst
- Superficial angiomyxoma
- Benign vascular tumours
- Angiolymphoid hyperplasia
- Angiomatosis
- Atypical vascular lesion
- Epithelioid hemangioma
- Gorham disease
- Hemangioma
- Intra-muscular hemangioma
- Lymphangioma
- Pyogenic granuloma
- Osseous pseudo-tumours
- Bizarre parosteal osteochondromatous proliferation
- Callus
- Florid ossificans periostitis
- Post-traumatic fibro-osseous lesion
- Tophaceous pseudogout
- Other benign lesion
- GIST
- gastrointestinal stromal tumour (GIST), low, very low risk
- gastrointestinal stromal tumour (GIST), intermediate risk
- gastrointestinal stromal tumour (GIST), high risk
- Non-mesenchymal malignant tumour
- Carcinoma
- Germinal tumor
- Lymphoma
- Melanoma
- Myeloma
- Other non-mesenchymal malignant tumours
- Plasmocytoma
- Other diagnoses
- Diagnosis unspecified
- Undifferentiated malignant tumour
- Sarcoma
- Chondrosarcoma
- Central chondrosarcoma
- Chondrosarcoma NOS
- Clear cell chondrosarcoma
- Dedifferentiated chondrosarcoma
- Mesenchymal chondrosarcoma
- Periosteal chondrosarcoma
- Peripheral chondrosarcoma
- Leiomyosarcoma
- Leiomyosarcoma - differentiated
- Leiomyosarcoma - poorly-differentiated
- Liposarcoma
- Liposarcoma - dedifferentiated
- Liposarcoma - mixed type
- Liposarcoma - myxoid
- Liposarcoma - NOS
- Liposarcoma - pleomorphic
- Liposarcoma - round cell
- Liposarcoma - well differentiated
- Malignant peripheral nerve sheath tumour
- Ectomesenchymoma
- Malignant perineurioma
- Malignant Triton tumour
- MPNST - epithelioid type
- MPNST - usual type
- Miscellaneous sarcomas
- Adult fibrosarcoma
- Alveolar soft part sarcoma
- Angiosarcoma
- BCOR sarcoma
- CIC-DUX sarcoma
- Clear cell sarcoma
- Desmoplastic round cell tumour
- Epithelioid hemangioendothelioma
- Epithelioid sarcoma
- Ewing sarcoma
- Extraskeletal myxoid chondrosarcoma
- High risk solitary fibrous tumour
- Intimal sarcoma
- Low grade fibromyxoid sarcoma
- Low grade sinonasal sarcoma
- Malignant glomus tumour
- Malignant granular cell tumour
- Malignant mesenchymoma
- Malignant mixed tumor
- Malignant myoepithelial tumour
- Malignant ossifying fibromyxoid tumour
- Malignant PECOMA
- Malignant rhabdoid tumour
- Malignant tenosynovial giant cell tumour
- Sclerosing epithelioid fibrosarcoma
- SMARCA4-deficient thoracic sarcoma
- Myxofibrosarcoma
- Osteosarcoma
- Conventional osteosarcoma
- Dedifferentiated low-grade central osteosarcoma
- Dedifferentiated parosteal osteosarcoma
- Extraskeletal osteosarcoma
- High-grade surface osteosarcoma
- Low-grade central osteosarcoma
- Osteoblastoma-like osteosarcoma
- Osteosarcoma NOS
- Parosteal osteosarcoma
- Periosteal osteosarcoma
- Small cell osteosarcoma
- Telangiectasic osteosarcoma
- Other sarcomas
- Adamantinoma
- Adenosarcoma
- Chordoma
- Dedifferentiated adamantimoma
- Dedifferentiated chordoma
- Endometrial stromal sarcoma
- Endometrial stromal sarcoma - high-grade
- Endometrial stromal sarcoma - low-grade
- Phyllodes sarcoma
- Undifferentiated uterine sarcoma
- Rhabdomyosarcoma
- Adult spindle cell rhabdomyosarcoma
- Alveolar rhabdomyosarcoma
- Embryonal rhabdomyosarcoma - botryoid type
- Embryonal rhabdomyosarcoma - NOS
- Embryonal rhabdomyosarcoma - spindle cell type
- Embryonal rhabdomyosarcoma - usual type
- Pleomorphic rhabdomyosarcoma
- Rhabdomyosarcoma - NOS
- Sclerosing rhabdomyosarcoma
- Spindle cell rhabdomyosarcoma
- Suspicion of sarcoma
- Synovial sarcoma
- Synovial sarcoma - biphasic
- Synovial sarcoma - monophasic
- Synovial sarcoma - NOS
- Synovial sarcoma - poorly differentiated
- Undifferentiated sarcoma
- Dermal pleomorphic sarcoma
- Undifferentiated epithelioid sarcoma
- Undifferentiated pleomorphic sarcoma
- Undifferentiated round cell sarcoma
- Undifferentiated sarcoma - NOS
- Undifferentiated spindle cell sarcoma
- Tumour of intermediate malignancy
- Atypical lipomatous tumour
- Intermediate chondrogenic tumours
- Atypical cartilaginous Tumour/Chondrosarcoma grade 1
- Cartilaginous tumour of uncertain prognosis
- Chondroblastoma
- Chondromyxoid fibroma
- Intermediate fibroblastic/myofibroblastic tumours
- Dermatofibrosarcoma protuberans
- Desmoid-type fibromatosis
- Desmoplastic fibroma of bone
- Fibro-osseous tumour of bone NOS
- Fibrosarcomatous dermatofibrosarcoma protuberans
- Giant cell fibroblastoma
- Infantile fibrosarcoma
- Inflammatory myofibroblastic tumour
- Lipofibromatosis
- Low grade myofibroblastic sarcoma
- Myxoinflammatory fibroblastic sarcoma
- Palmar/plantar fibromatosis
- Solitary fibrous tumour
- Intermediate fibrohistiocytic tumours
- Giant cell tumour of bone
- Giant cell tumour of soft tissues
- Malignant/dedifferentiated giant cell tumour of bone
- Metastatic giant cell tumour of bone
- Osseous tumour rich in giant cell NOS
- Plexiform fibrohistiocytic tumour
- Suspicion of giant cell tumour of bone
- Intermediate osteogenic tumours
- Osteoblastoma
- Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma)
- Intermediate tumours of uncertain differentiation
- Aneurysmal bone cyst
- Angiomatoid fibrous histiocytoma
- Atypical fibroxanthoma
- Erdheim-Chester disease
- Hemosiderotic fibrolipomatous tumour
- Langerhans cell histiocytosis
- Lymphangioleiomyoma/lymphangioleiomyomatosis
- Melanotic neuroectodermal tumour of infancy
- Mixed tumour
- Myoepithelioma
- Ossifying fibromyxoid tumour
- PECOMA - NOS
- Phosphaturic mesenchymal tumour
- Intermediate vascular tumours
- Composite hemangioendothelioma
- Epitheliod vascular tumour of bone NOS
- Kaposi sarcoma
- Kaposiform hemangioendothelioma
- Papillary intralymphatic angioendothelioma
- Pseudomyogenic hemangioendothelioma
- Retiform hemangioendothelioma
- Lipomatous spindle cell/pleomorphic tumour of malignant potential
- Other tumours of intermediate malignancy
- Endometrial stromal nodule
- Metastatic leiomyoma
- Smooth muscle tumour of undetermined malignant potential (STUMP)
- Uterine tumour resembling ovarian sex cord tumours (UTROSCT)

Date of original diagnosis

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description : Date of the first sampling which allowed the diagnosis of the current tumour

Age at diagnosis

Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No

Description :

Diagnosis changed

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Modification de diagnostic (diagnostic redressé) suite à la relecture anapath. Exemple : en 2010 diagnostic de lipome relecture des lames en 2013 diagnostic de liposarcome le diagnostic est redressé donc Diagnosis changed = Yes. Exemple : diagnostic liposarcome bien différencié qui devient après rechute un liposarcome indifférentié. Diagnosis changed = No.

Possible values :
No, Yes

Initial diagnosis

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Quel était le diagnostic avant que le redressement de diag ?

Date of review

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description : Date à laquelle la relecture anapath a permis de redresser le diagnostic.

Grade of tumour

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Histologic grade of the primary tumour according to the French grading system: tumour differentiation score 1 to 3, 0) + mitotic index (score 1 to 3, 0) + tumour necrosis (score 0 to 2, 0) Grade=1 for total score of 2 or 3 Grade=2 for total score of 4 or 5 Grade=3 for total score of 6, 7 or 8

Possible values :
1, 2, 3, NA

Mitotic Index / 50HPF

Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No

Description :

Miettinen/AFIP

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Risque de malignité des GIST selon Miettinen

Possible values :
Very low risk, Low risk, Intermediate risk, High risk, NA

Radiation area

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes : tumour developed in a previously irradiated area

Possible values :
No, Yes

Lymphoedema

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes : tumour developed in a region with a preexisting lymphoedema

Possible values :
No, Yes

Loco-regional extension

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description : Tumour invasion of healthy adjacent tissues (NB: a deep intramuscular tumour systematically invades the adjacent muscle)

Possible values :
No, Dermis, Hypodermis, Vasculo-nervous, Bone, Muscle, Adjacent organ

Multifocal tumour

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : No: when tumour is only one entity Yes: when tumour is one entity associated with one or more nodules

Possible values :
No, Yes

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes when there is a locoregional lymph node involvement detected by clinical and/or imaging evaluation

Possible values :
No, Yes

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes when there is a distant metastasis diagnosed by imaging and / or histological evaluation

Possible values :
Yes, No, Skip

StatusAtReferral

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
First event, Relapse

TTTBeforeReferral

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Yes

Performance status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : 0 Fully active, able to carry out all pre-disease performance without restriction1 (Restricted) impairment in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work2 Ambulatory and capable of all selfcare but unable to carry out any work activities for more than 50% of waking hours3 Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours4 Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair

Possible values :
0, 1, 2, 3, 4, NA

Cancer status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Cancer status at last contact

Possible values :
No evidence of this cancer, Evidence of this cancer, Unknown, Not Applicable

ImagingBeforeTTT

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
No, Ultrasound, CT Scan, MRI, X-Ray (standard radiograph), Other, Not available

PathoFracture

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Yes

Surgery of tumour

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Yes, Curettage

Date of surgery

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description : Date of surgery

Time of surgery

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
First, Second, Third

Type of surgery of tumour

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Excision: removal of the tumour with no normal tissue at least of the surface of the tumour Wide resection: removal of the tumour with normal tissue covering all the surface of the tumour Compartimentectomy: removal of the tumour with all the tissues contained in an anatomical compartiment Amputation (of a limb or of the distal part of a limb such as a hand, foot or finger, 0)

Possible values :
Excision, Wide resection, Compartimentectomy, Amputation

Surgeon

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Chirurgien qui a opéré la tumeur primaire Les chirurgiens Sarcome sont listés dans Network. Si la RCP propose que l'opération soit faite par un chirurgien particulier qui ne fait pas parti du réseau mais dont le nom est donné lors de la RCP il doit être saisi dans Referral to a specialized surgery outside network. Si le chirurgien ne correspond pas aux situations précédentes alors saisir Outside network.

Possible values :
- Network
- ALIFANO Marco (Paris)
- ANRACT Philippe (Paris)
- BABINET Antoine (Paris)
- BALLAS Richard (La Reunion)
- BAQUE Patrick (Nice)
- BASSELOT Frédéric (Rennes)
- BERGER Anne (Paris)
- BIAU David (Paris)
- BLONDET Remi (Lyon)
- BODIN Frédéric (Strasbourg)
- BONNEVIALLE Paul (Toulouse)
- BONVALOT Sylvie (Paris)
- BRIAND Sylvain (Nantes)
- BRINKERT David (Strasbourg)
- BROUCHET Laurent (Toulouse)
- BRUCHON Yvonnic (Dijon)
- BRULEFERT Kevin (Nantes)
- BURNIER Pierre (Dijon)
- CARRERE Sebastien (Montpellier)
- CARRET Jean-Paul (Lyon)
- CAUSERET Sylvain (Dijon)
- CAVALCANTI Andrea (Villejuif)
- CHAMMAS Michel (Montpellier)
- CHAPELIER Alain (Paris)
- CHOTEL Franck (Lyon)
- COLOMBO Emmanuel (Montpellier)
- COSTAZ Hélène (Dijon)
- COURT Charles (Villejuif)
- COUTANT Charles (Dijon)
- COUTURAUD Benoit (Paris)
- CRENN Vincent (Nantes)
- CUISENIER Jean (Dijon)
- CURVALE Georges (Marseille)
- DAUTEL Gilles (Nancy)
- DE BILLY Benoit (Besançon)
- DECANTER Gauthier (Lille)
- DELROEUX Delphine (Besancon)
- DESFOURNEAUX Véronique (Rennes)
- DESOLNEUX Grégoire (Bordeaux)
- DIDELOT Stéphane (Montpellier)
- DI MARCO Antonio (Strasbourg)
- DOUSSET Bertrand (Paris)
- DUJARDIN Franck (Rouen)
- DUMAINE Valérie (Paris)
- DUNET Julien (Caen)
- DUPRE Aurelien (Lyon)
- ENKAOUA Eric (Paris)
- EVEN Julien (Paris)
- FABRE Thierry (Bordeaux)
- FAKHRY Nicolas (Marseille)
- FARON Matthieu (Villejuif)
- FAU Magali (Nancy)
- FERRON Gwenael (Toulouse)
- FIORENZA Fabrice (Limoges)
- FOUCHE Yves (Nice)
- FRAISSE Bernard (Rennes)
- FRAISSE Jean (Dijon)
- FRON Damien (Lille)
- FUENTES Stephane (Marseille)
- GANGLOFF Dimitri (Toulouse)
- GARRET Jérome (Lyon)
- GAY André (Marseille)
- GHOUTI Laurent (Toulouse)
- GICQUEL Philippe (Strasbourg)
- GILLERON Matthieu (Rouen)
- GILLES Olivier (Bordeaux)
- GIMBERGUES Pierre (Clermond-Ferrand)
- GOUIN Francois (Nantes/Lyon09/2018)
- GUILLEMIN François (Reims)
- GUILLOIT Jean-Marc (Caen)
- GUINARD Didier (Marseille)
- GUIRAMAND Jerome (Marseille)
- GUYARD Matthieu (Lyon)
- GUYON Frédéric (Bordeaux)
- HAMEL Antoine (Nantes)
- HAMEURY Frederic (Lyon)
- HARDWIGSEN Jean (Marseille)
- HARNOY Yann (Rennes)
- HONORE Charles (Villejuif)
- IHRAI Tarik (Nice)
- JACOPIN Samuel (La Reunion)
- JAFARI Mehrdad (Lille)
- JANKOWSKI Clémentine (Dijon)
- JEGOUX Franck (Rennes)
- JOUVE Jean-Luc (Marseille)
- LAFFOSSE Jean-Michel (Toulouse)
- LAVOUE Vincent (Rennes)
- LAZERGES Cyril (Montpellier)
- LE NAIL Louis-Romée (Tours)
- MACHEBOEUF Yvan (Dijon)
- MACHIAVELLO Jean-Christophe (Nice)
- MARCHAL Frédéric (Nancy)
- MARCO Oren (Paris)
- MARIANI Pascale (Paris)
- MARY Pierre (Paris)
- MASCARD Eric (Paris)
- MATTEI Jean-Camille (Marseille)
- MAURY Philippe (Montpellier)
- MAYNOU Carlos (Lille)
- MEEUS Pierre (Lyon)
- MEGY Bernard (Nimes)
- MENSA Christophe (Reims)
- MERESSE Thomas (Toulouse)
- MEUNIER Bernard (Rennes)
- MEZEL Aurélie (Lille)
- MICHEL Jean-Luc (La Reunion)
- MICHOT Audrey (Bordeaux)
- MIGAUD Henri (Lille)
- MISSENARD Gilles (Villejuif)
- MOUSSELARD Pascal (Paris)
- ORRY David (Dijon)
- OZIL Camille (Paris)
- PADEANO Marie-Martine (Dijon)
- PANNIER Stéphanie (Paris)
- PAUCHOT Julien (Besancon/Clermont2018)
- PEYRAT Patrice (Lyon)
- PLUVY Isabelle (Besancon)
- POLYCARPE Emmanuel (Caen)
- POP Daniel (Nice)
- QUENET François (Montpellier)
- RAUX Sebastien (Lyon)
- REGENET Nicolas (Nantes)
- REVOL Marc (Paris)
- RICHARD DE LA TOUR Bertrand (Rennes)
- RIMAREIX Francoise (Villejuif)
- RIVOIRE Michel (Lyon)
- ROCHCONGAR Goulven (Caen)
- ROCHWERGER Alexandre (Marseille)
- ROPARS Mickael (Rennes)
- ROSSET Philippe (Tours)
- ROUANET Philippe (Montpellier)
- RUZIC Jean-Christophe (La Reunion)
- SAUVAT Frédérique (La Reunion)
- SIRVEAUX François (Nancy)
- STOECKLE Eberhard (Bordeaux)
- SULPICE Laurent (Rennes)
- SZYMANSKI Christophe (Lille)
- TABUTIN Mayeul (Lyon)
- TEMAM Stéphane (Villejuif)
- TESSIER William (Lille)
- THEVENIN-LEMOINE Camille (Toulouse)
- THOMAS Pascal (Marseille)
- THOULOUZAN Mathieu (Toulouse)
- TZANIS Dimitrios (Paris)
- VALLEE Antoine (Rouen)
- VAZ Gualter (Lyon)
- VERHAEGHE Jean-Luc (Nancy)
- VIARD Brice (Dijon)
- VINCELET Yannick (Nancy)
- VIOLAS Philippe (Rennes)
- WAAST Denis (Nantes)
- Referral to a specialized surgery outside network
- Outside network

Re-excision

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Reprise chirurgicale tumeur primaire Ne sont prises en compte que les reprises chirurgicales ayant lieu avant la progression ou la rechute.

Possible values :
No, Yes, Curettage

Re-excision surgeon

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Chirurgien qui a ré-opéré la tumeur primaire Les chirurgiens sarcome sont listés dans Network. Si la RCP propose que la reprise soit faite par un chirurgien particulier qui ne fait pas parti du réseau mais dont le nom est donné lors de la RCP il doit être saisi dans Referral to a specialized surgery outside network. Si le chirurgien ne correspond pas aux situations précédentes alors saisir Outside network.

Tumour spillage (CTCB)

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Expert pathologist observed if the tumour was spilt

Possible values :
Yes, No

Margin R

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : R0: complete tumour resection at the macroscopic (surgeon, 0) and histological (pathologist, 0) levels R1: complete tumour resection at the macroscopic level (surgeon, 0) with tumour cells on the margins at the histological examination If the tumour is seen by the surgeon, it should be classified as R1. For most retroperitoneal tumours, the resection is R1. R2: incomplete tumour resection at the macroscopic level (surgeon, 0)

Possible values :
R0, R1, R2, Not evaluable

ResidualTCells

Type : Free value
Content : PERCENTAGE
Mandatory : No
Multiple values : No
Unique : No

Description :

BoneReconstruction

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Prothesis, Autograft, Biomaterials

ComplicationSurgery

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Henderson 1, Henderson 2, Henderson 3, Henderson 4

Isolated limb perfusion

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Isolated limb perfusion

Possible values :
No, Yes

DILP

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

SystemicTTT

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Yes

ChemotherapyOfTumour

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : No: no chemotherapy for the primary tumour. Neoadjuvant: chemotherapy has been the first treatment performed. Adjuvant: chemotherapy has been performed after a complete remission of the tumour. Neoadjuvant + adjuvant: chemotherapy has been performed both as a first treatment and after a complete remission of the tumour. Palliative: chemotherapy has been performed with no curative intend (metastatic disease or tumour locally advanced, 0)

Possible values :
No, Neoadjuvant, Adjuvant, Neoadjuvant + adjuvant, Palliative

DSytTTTStart

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

DSystTTTEnd

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

IndicSystTTT

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available

Radiotherapy of tumour

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : No: no radiotherapy for the primary tumour First: radiotherapy has been the first treatment performed Second: radiotherapy has been performed after another treatment such as surgery

Possible values :
No, First, Second, Third, Palliative

DRTEStart

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

DRTEEnd

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

Dose of radiotherapy

Type : Free value
Content : DECIMAL
Mandatory : No
Multiple values : No
Unique : No

Description : Total dose of radiotherapy given to the primary tumour and expressed in Grays

Hormonotherapy

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: when the patient was treated by hormonotherapy

Possible values :
No, Yes

DHormonoTStart

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

AINS

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: when the patient was treated by AINS

Possible values :
No, Yes

DAINSStart

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

OtherTTT

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
No, Radiofrequency, Cryotherapy, Embolisation, Other

Clinical trial

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour

Possible values :
No, Yes

Locoregional control

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes : no residual tumour at the primary site by clinical and imaging examinations

Possible values :
Yes, No, Not available

Complete remission after treatment

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : There is no evidence of residual tumour at the end of treatment of the tumour by clinical (and imaging when performed, 0) evaluation.

Possible values :
Yes, No

Local recurrence (38 items)

Rank of local recurrence

Type : Free value
Content : INTEGER
Mandatory : Yes
Multiple values : No
Unique : No

Description : Rank of local recurrence

Date of local recurrence

Type : Free value
Content : DATE
Mandatory : Yes
Multiple values : No
Unique : No

Description : Date of diagnosis of the first local recurrence

Size of tumour (mm)

Type : Free value
Content : DECIMAL
Mandatory : No
Multiple values : No
Unique : No

Description : Largest diameter of the tumour expressed in mm

Depth of tumour

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Possible values :
Superficial, Superficial and deep, Deep, Surface, Cortical, Intra-medullary

Multifocal tumour

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : No: when tumour is only one entity Yes: when tumour is one entity associated with one or more nodules

Possible values :
No, Yes

Radiation area

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes : tumour developed in a previously irradiated area

Possible values :
No, Yes

Performance status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Possible values :
0, 1, 2, 3, 4, NA

PathoFracture

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Yes

Surgery of tumour

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Yes, Curettage

Date of surgery

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description : Date of surgery

Time of surgery

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
First, Second, Third

Type of surgery of tumour

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Possible values :
Excision, Wide resection, Compartimentectomy, Amputation

SurgeonLR

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Network, Outside Network

Re-excision

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Reprise chirurgicale tumeur primaire Ne sont prises en compte que les reprises chirurgicales ayant lieu avant la progression ou la rechute.

Possible values :
No, Yes, Curettage

ReExcisionSurgeonLR

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Network, Outside Network

Tumour spillage (CTCB)

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Expert pathologist observed if the tumour was spilt

Possible values :
Yes, No

Margin R

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Possible values :
R0, R1, R2, Not evaluable

ResidualTCells

Type : Free value
Content : PERCENTAGE
Mandatory : No
Multiple values : No
Unique : No

Description :

BoneReconstruction

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Prothesis, Autograft, Biomaterials

ComplicationSurgery

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Henderson 1, Henderson 2, Henderson 3, Henderson 4

SystemicTTT

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Yes

DSytTTTStart

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

DSystTTTEnd

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

IndicSystTTT

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available

Isolated limb perfusion

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Isolated limb perfusion

Possible values :
No, Yes

DILP

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

Radiotherapy of tumour

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : No: no radiotherapy for the primary tumour First: radiotherapy has been the first treatment performed Second: radiotherapy has been performed after another treatment such as surgery

Possible values :
No, First, Second, Third, Palliative

DRTEStart

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

DRTEEnd

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

Dose of radiotherapy

Type : Free value
Content : DECIMAL
Mandatory : No
Multiple values : No
Unique : No

Description : Total dose of radiotherapy given to the primary tumour and expressed in Grays

Hormonotherapy

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: when the patient was treated by hormonotherapy

Possible values :
No, Yes

DHormonoTStart

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

AINS

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: when the patient was treated by AINS

Possible values :
No, Yes

DAINSStart

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description :

Clinical trial

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour

Possible values :
No, Yes

OtherTTT

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
No, Radiofrequency, Cryotherapy, Embolisation, Other

Locoregional control

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes : no residual tumour at the primary site by clinical and imaging examinations

Possible values :
Yes, No, Not available

Complete remission after treatment

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : There is no evidence of residual tumour at the end of treatment of the tumour by clinical (and imaging when performed, 0) evaluation.

Possible values :
Yes, No

Metastatic disease (8 items)

Location of first metastasis

Type : Constrained
Content : TEXT
Mandatory : Yes
Multiple values : Yes
Unique : No

Description : Location of first metastasis

Possible values :
Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other

Date of first metastasis

Type : Free value
Content : DATE
Mandatory : Yes
Multiple values : No
Unique : No

Description : Date of diagnosis of the first metastasis

Number of metastatic sites

Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No

Description : Number of metastasic sites at diagnosis

Location of further metastasis

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description : Location of further metastasis

Possible values :
Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other, No

TTTM

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
No, Systemic treatment, Locoregional treatment, AINS, Other

Locoregional treatment of metastasis

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description : Choose one or several (CTRL + clic) type(s) of locoregional treatment for the treatment of metastasis

Possible values :
Surgery, Radiofrequency, Cryotherapy, Radiotherapy, Other

IndicSystTTT

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available

Clinical trial

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour

Possible values :
No, Yes

Sample (13 items)

Sample reference

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : Yes

Description : The sample reference in the center

Date of sampling

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description : Date on which the sample was removed

Metastasis sample location

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Location of this metastasis sample (only for metastasis sample)

Possible values :
Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other

Treatment before sampling

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description : No : no treatment of the tumour event before sampling Chemotherapy: the tumour event has been received a chemotherapy before sampling Radiotherapy: radiotherapy on the tumour event before sampling ILP: an isolated limb perfusion procedure has been performed on the tumour event before sampling Other: other treatment has been performed on the tumour event before sampling

Possible values :
No, Systemic treatment, Radiotherapy, ILP, Other

Type of sampling

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Microbiopsy: sampling of the tumour with a core needleOpen biopsy: surgical resection of a piece of the tumour with a diagnostic intendTumour resection: surgical resection of the whole tumour

Possible values :
Microbiopsy, Open biopsy, Tumour resection, Curettage

Immunohistochemistry

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Yes

FISH

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Yes

Result FISH

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
In progress, Negative, Non interpretable, Positive

Molecular Biology

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Molecular Biology techniques performed

Possible values :
No, Yes

Result (Molecular Biology)

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
In progress, Negative, Positive, Non interpretable

Frozen tissue

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Yes

Paraffin available

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Yes

Virtual slide

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Paraffin (9 items)

Number of paraffin blocks with tumour

Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No

Description : Number of paraffin blocks with tumour available in your Centre

TMA

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: if sample of paraffin block is included in a TMA (Tissue Micro Array)

Possible values :
No, Yes

Storage centre

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Centre where TMA is stored

Possible values :
ANGERS, ARTTIC, BERGONIE, BRUXELLES, CAEN, CCRC, CLERMONT-FERRAND, Cochin, CURIE, DIJON, ERASM, HENRI MONDOR, ICR, IGR, INT, IPSO, KLEUVEN, LAUSANNE, LBPA, LCC, LILLE, MARSEILLE CHU, MARSEILLE IPC, MAUNIHEI, MONTPELLIER, NANCY, NANTES, NICE, P-MAR, Paris Ouest, Rennes, SAINT-CLOUD, SANAV, SLS, STRASBOURG, TOULOUSE, UCBL, UNIPD, Warsaw Cancer Center, Bonn University

Array-CGH

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: array-CGH done

Possible values :
Not done, Done non interpretable, Done interpretable

Genomic index

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Value of genomic index

Possible values :
GI1, GI2

RNASeq

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Not done, Done non interpretable, Done interpretable

ExomeSeq

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Not done, Done non interpretable, Done interpretable

MethylSeq

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Not done, Done non interpretable, Done interpretable

Web review

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes : if the case has been reviewed using virtual slide

Possible values :
No, Yes

Frozen tissue (17 items)

Storage temperature

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Storage temperature of the frozen material according to the scroll menu

Possible values :
-80°C, -140°C, Liquid nitrogen

Availability of tissue sample

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Available: frozen material has not been used and is available in the local Center In use: frozen material is currently in use in one or several studies Terminated: there is no frozen material left but nucleic acids (DNA and/or RNA, 0) may be still available

Possible values :
Terminated, In use, Available

Number of tubes

Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No

Description : Number of tubes containing tumour fragments stored

Specific translocation

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: karyotype showes a translocation

Possible values :
t(X;17)(p11;q25) (Alveolar soft part sarcoma), t(9;22)(q22;q12) (Extraskeletal myxoid chondrosarcoma), t(9;17)(q22;q11) (Extraskeletal myxoid chondrosarcoma), t(9;15)(q22;q21) (Extraskeletal myxoid chondrosarcoma), t(12;22)(q13;q12) (Clear cell sarcoma), t(11;22)(p13;q12) (Desmoplastic small round cell tumor), t(17;22)(q21;q13) (Dermatofibrosarcoma protuberans), t(11;22)(q24;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(21;22)(q22;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(7;22)(p22;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(17;22)(q12;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(2;22)(q33;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(1;16)(q21;q13) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(12;16)(q13;p11) (Liposarcoma, myxoid/round cell), t(12;22)(q13;q12) (Liposarcoma, myxoid/round cell), t(2;13)(q35;q14) (Alveolar rhabdomyosarcoma), t(1;13)(p36;q14) (Alveolar rhabdomyosarcoma), t(X;18)(p11;q11) (Synovial sarcoma)

Array-CGH

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: array-CGH done

Possible values :
Not done, Done non interpretable, Done interpretable

Genomic index

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Value of genomic index

Possible values :
GI1, GI2

RNA expression profile

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: expression profile done

Possible values :
Not done, Done non interpretable, Done interpretable

CINSARC

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Value of CINSARC

Possible values :
C1, C2

SNP analysis

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: SNP analysis done

Possible values :
Not done, Done non interpretable, Done interpretable

miRNA analysis

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: miRNA analysis done

Possible values :
Not done, Done non interpretable, Done interpretable

RNASeq

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Not done, Done non interpretable, Done interpretable

ExomeSeq

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Not done, Done non interpretable, Done interpretable

MethylSeq

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Not done, Done non interpretable, Done interpretable

Whole Genome Sequencing

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Not done, Done non interpretable, Done interpretable

Karyotyping

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: karyotype done

Possible values :
Not done, Done

Vamp ID

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Weight of frozen tissue

Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No

Description : Total weigh of frozen tumours fragments in mg

Cell line (11 items)

Cell line reference

Type : Free value
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : Yes

Description : The cell line reference in the center

Number of passages

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Number of passages after put in culture of cells

Possible values :
-30, +30

Dilution

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Dilution done at each passage

Possible values :
1/2, 1/4, 1/8, 1/10

Passage frequency

Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No

Description : Number of days between 2 passages

Molecular validation

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Method to check cells are tumorous by chromosome spreading, FISH or sequencing

Possible values :
Yes, No, Not available

Array-CGH

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: array-CGH done

Possible values :
Not done, Done non interpretable, Done interpretable

Genomic index

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Value of genomic index

Possible values :
GI1, GI2

RNA expression profile

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: expression profile done

Possible values :
Not done, Done non interpretable, Done interpretable

CINSARC

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Value of CINSARC

Possible values :
C1, C2

miRNA analysis

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: miRNA analysis done

Possible values :
Not done, Done non interpretable, Done interpretable

MultiFISH

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: multiFISH done

Possible values :
not done, done interpretable, not interpretable

Blood sample (7 items)

Sample reference

Type : Free value
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : Yes

Description : The sample reference in the center

Date of sampling

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description : Date on which the sample was removed

Treatment before sampling

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Possible values :
No, Systemic treatment, Radiotherapy, ILP, Other

Type of material

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Type of material stored

Possible values :
Serum, Plasma, Lymphocytes, Total blood

Consent

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: consent obtained from the patient

Possible values :
Yes, No, NA

Storage centre

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Centre where TMA is stored

Whole Genome Sequencing

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Not done, Done non interpretable, Done interpretable

Chemotherapy line (9 items)

Rank of Chemotherapy line

Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No

Description : Rank of Chemotherapy line

Date of first cycle

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description : Date of first cycle of chemotherapy

Performance status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Possible values :
0, 1, 2, 3, 4, NA

Drugs

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
90Y-Ibritumomab tiuxetan, Abraxane, Abemaciclib, ADEPT, AINS, Aldesleukin, Aldoxorubicin, Alemtuzumab, AMG 706, Amsacrine, Atezolizumab, Avapritinib, Azacitidine, Bendamustine, Bevacizumab, BI2536, BKM120, Bleomycin, Bortezomib, Brostallicin, Busulfan, Cabazitaxel, Capecitabine, Carboplatin, Cabozantinib, Carmustine, Ceritinib, Cetuximab, Chlorambucil, Cisplatin, Cixutumumab, Cladribine, Clofarabine, Conatumumab, Crenigacestat, Crisantaspase, Crizotinib, Cyclophosphamide, Cytarabine, Dacarbazine, Dactinomycin, Dalotuzumab, Dasatinib, Daunorubicin, DCC-2618, Deforolimus, Denosumab, Docetaxel, Dovitinib, Doxorubicin, Durvalumab, Emactuzumab, Epirubicin, Eribulin, Erlotinib, Etoposide, Everolimus, Evofosfamide, Fludarabine, Fluorouracil, Fotemustin, FPA0008, Fulvestrant, Gefitinib, Gemcitabine, Gemtuzumab, Gimatecan, Gliadel implants, Halichondrin B, HDM201, Hormonotherapy, Hydroxycarbamide, Idarubicin, Ifosfamide, Imatinib, Interferon alpha, Interleukin-2, Iodine-131 tositumomab, Ipilimumab, Irinotecan, Lapatinib, Larotrectinib, Lenalidomide, Leucovorin, Liposomal daunorubicin, Liposomal doxorubicin, Lomustine, Masitinib, Melphalan, Mercaptopurine, Mesna, Methotrexate, Mitomycin, Mitotane, Mitoxantrone, Motesanib, NGR-hTNF, Nilotinib, Nintedanib, Nivolumab, Olaparib, Olaratumab, Ombrabulin, Ontuxizumab (MORAb-004), Oxaliplatin, Paclitaxel, Palbociclib, Palifosfamide, Panitumumab, Panobinostat, Pazopanib, Pembrolizumab, Pemetrexed, Pentostatin, Pexidartinib, Ponatinib, Prednisolone, Procarbazine, R1507 (Teprotumumab), Raltitrexed, Ramucirumab, Rasburicase, Regorafenib, Ribociclib, Ridaforolimus, Rituximab, RO5045337 / RG7112 (Nutlin), Satraplatin, Sirolimus, Sorafenib, Streptozocin, Sunitinib, Tamoxifen, Tazemetostat, Tegafur-uracil, Temozolomide, Temsirolimus, Thalidomide, Thiotepa, Tioguanine, Topotecan, Trabectedin, Trastuzumab, Treosulfan, Vinblastine, Vemurafenib, Vincristine, Vindesine, Vinorelbine, Warfarin, Other

Clinical trial

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour

Possible values :
No, Yes

Clinical trial name

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Clinical trial name according to the scroll menu

Possible values :
Clinical trial name to complete, 105SAR301 TAPPAS, 20140114, AB04030, AB07001, AB1010, AB11002, ACSE Pembrolizumab, ALDOXORUBICIN, ALTGIST, AMG706, AMGEN 20060324, ANGIO-NEXT, ANGIOTAX, ANGIOTAX-PLUS, ANNOUNCE 1, ASCEND10, BAY734506, BET115521, BFR14, BKM120, BLU-285-1101, BLU-285-1303 , BP27772, CA017-003, CA209-848, CABOGIST, CAMN107, CGM097, CHDM201X2103C, COMBINAIR 3, CRAD001C2206, CRAD001X2109, CREATE, CSTI571X2103, CYCLIGIST, DESMOPAZ, DOVIGIST, E7438-G000-101, EFC 10145, EISAI E7389, EORTC 1202, EORTC-1447-STBSG, EORTC-1506-STBSG-ANITA, EORTC 62005, EORTC-62012, EORTC-62022-IRESSA , EORTC-62024, EORTC-62043, EORTC-62052, EORTC-62061-STBSG, EORTC 62113-55115 HGUS, EORTC-62972, EORTC-90061-BI2536, EORTC STI571, ESTIM-LBH, ETC-002-07, EURO-EWING, EUROSARC, EZH-102 (EPIZYME), EZH-202, EZH-501, FIVE PRIME, GCS O12, GEIS-32, GIMATECAN, GP28153, H6Q-MC-JCAY, I3G-MC-JGCB, I5B-MC-JGDJ : ANNOUNCE, I5B-MC-JGDL : ANNOUNCE 2, I5B-MC-JGDM, I6F-MC-JJCD, IMCLONE, IMADGIST, INVICTUS, IROFULVEN, KCP-330-020 SEAL, KIDES-203, LEE011, LMS02, LMS03, LMS04, MEKi, MEN 10755, METRO-PD1, METROMAJX, METZOLIMOS, MMT 95, MO29518 basket, MOLMED, MORAb-004, MOST, NEOSARCOMICS, NP27872, NP28021, OP690, PAL-ANGI3, PALETTE, PALSAR, PALSAR II, PAZOGIST, PEMBROSARC, PICASSO, PICASSO 3, PLX108-10, PO4720, PVNS, RADIOSARP, REGOBONE, REGO-SARC, RT-IMMUNE, RT-SUTENT, SAKK 56/07, SAR-1001, SAR04/0205, SARC011 R1507, SARC021-THRESHOLD, SARCOME 13, SCH717454, SHIVA, STI 571, SU011248, SUCCEED, SYNFRIZZ, TAIL, TARMIC, TAXOGEM, T-DIS, TH-CR-406, TH302, TRAMUNE, TRAST, TRUST, TSAR, VEBASKET, VEG105430 , VINFLUNINE IN104, VIT-0910, XGEVA AMGEN

Progression chemo

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Yes: the patient had progressive disease at the date of last-follow up; no: no progressive disease observed at the date of last follow-up

Possible values :
Yes, No, Not available

Date progression chemo

Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No

Description : Date of tumour progression under chemotharapy

Best RECIST Response chemo

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : Best response observed during chemotherapy: complete response; partial response; stable disease or progressive disease

Possible values :
Complete response, Partial response, Stable disease, Progressive disease, Not evaluable

Immunohistochemistry (7 items)

Positive markers

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fos B , Fox2B, FoxL2, Fli1, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K36M (H3F3B), H3K27, HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, OCT-4, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, Tot, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

Positive focal markers

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K36M (H3F3B), H3K27, HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Pancytokeratin AE1/AE3, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, OCT-4, P16, P40, P53, P63, Pan-Leu, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, Tot, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

Positive diffuse markers

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, EBV (LMP), E-Cadherin, EGFr, EMA, HHF35, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, OCT-4, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, Tot, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

Negative markers

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NRAS (Q61R), NSE, NR3C4, NTRK1, NUT, OCT-4, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, Tot, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

Not interpretable markers

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM4, MDM2, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, OCT-4, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, Tot, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

Mib1%

Type : Free value
Content : PERCENTAGE
Mandatory : No
Multiple values : No
Unique : No

Description :

Other markers

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Molecular cytogenetics (76 items)

Translocation analysis

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Yes, No

GNAS status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Mutation, No mutation, No amplifiable DNA

TypeTechGNAS

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

RT-PCR

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
No, Yes

Positive transcript (RT-PCR)

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
Transcript (PNET), EWSR1-FLI1 (PNET), EWSR1-ERG (PNET), EWSR1-ETV1 (PNET), EWSR1-FEV (PNET), EWSR1-ETV4 (PNET), FUS-ERG (PNET), CIC-DUX4 (Ewing -like), BCOR-CCNB3 (Ewing-like), Transcript (synovial sarcoma), SSI8- SSX1 (synovial sarcoma), SSI8- SSX2 (synovial sarcoma), SSI8- SSX4 (synovial sarcoma), SSI8L1- SSX1 (synovial sarcoma), Transcript (alveolar rhabdomyosarcoma), PAX3-FOXOA1 (alveolar rhabdomyosarcoma), PAX7-FOXOA1 (alveolar rhabdomyosarcoma), PAX3-MLLT7 (alveolar rhabdomyosarcoma), PAX3-NCOA1 (alveolar rhabdomyosarcoma), EWSR1-WT1 (desmoplastic round cell tumour), Transcript (myxoid liposarcoma), FUS-DDIT3 (myxoid liposarcoma), EWSR1-DDIT3 (myxoid liposarcoma), EWSR1-ATF1 (clear cell sarcoma), Transcript (extraskeletal myxoid chondrosarcoma), EWSR1-NR4A3 (extraskeletal myxoid chondrosarcoma), TAF1168-NR4A3 (extraskeletal myxoid chondrosarcoma), TCF12-NR4A3 (extraskeletal myxoid chondrosarcoma), TFG-NR4A3 (extraskeletal myxoid chondrosarcoma), COL1A1-PDGFB (dermatofibrosarcoma protuberans), Transcript (low grade fibromyxoid sarcoma), FUS-CREB3L2 (low grade fibromyxoid sarcoma), FUS-CREB3L1 (low grade fibromyxoid sarcoma), ASPL-TFE3 (alveolar soft part sarcoma), ASPSCR1-TFE3 (alveolar soft part sarcoma), ETV6-NTRK3 (congenital fibrosarcoma), Transcript (endometrial stromal sarcoma), JAZF1/SUZ12 (endometrial stromal sarcoma), YWHAE-FAM22 (endometrial stromal sarcoma), YWHAE-NUTM22A/B (endometrial stromal sarcoma), PAX-MAML3 (sinonasal sarcoma) , PAX3-NCOA1 (sinonasal sarcoma), MYH9-USP6 (fasciitis), EWSR1-PATZ1, EWSR1-ETAF1, CLTC-ALK, hSNF5/INI1 (malignant rhabdoid tumors), EWSR1-CREB3L2, NAB2-STAT6, SRF-NCOA1, FUS/FEV, EWS/NFATc2

Negative transcript (RT-PCR)

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
Transcript (PNET), EWSR1-FLI1 (PNET), EWSR1-ERG (PNET), EWSR1-ETV1 (PNET), EWSR1-FEV (PNET), EWSR1-ETV4 (PNET), FUS-ERG (PNET), CIC-DUX4 (Ewing -like), BCOR-CCNB3 (Ewing-like), Transcript (synovial sarcoma), SSI8- SSX1 (synovial sarcoma), SSI8- SSX2 (synovial sarcoma), SSI8- SSX4 (synovial sarcoma), SSI8L1- SSX1 (synovial sarcoma), Transcript (alveolar rhabdomyosarcoma), PAX3-FOXOA1 (alveolar rhabdomyosarcoma), PAX7-FOXOA1 (alveolar rhabdomyosarcoma), PAX3-MLLT7 (alveolar rhabdomyosarcoma), PAX3-NCOA1 (alveolar rhabdomyosarcoma), EWSR1-WT1 (desmoplastic round cell tumour), Transcript (myxoid liposarcoma), FUS-DDIT3 (myxoid liposarcoma), EWSR1-DDIT3 (myxoid liposarcoma), EWSR1-ATF1 (clear cell sarcoma), Transcript (extraskeletal myxoid chondrosarcoma), EWSR1-NR4A3 (extraskeletal myxoid chondrosarcoma), TAF1168-NR4A3 (extraskeletal myxoid chondrosarcoma), TCF12-NR4A3 (extraskeletal myxoid chondrosarcoma), TFG-NR4A3 (extraskeletal myxoid chondrosarcoma), COL1A1-PDGFB (dermatofibrosarcoma protuberans), Transcript (low grade fibromyxoid sarcoma), FUS-CREB3L2 (low grade fibromyxoid sarcoma), FUS-CREB3L1 (low grade fibromyxoid sarcoma), ASPL-TFE3 (alveolar soft part sarcoma), ASPSCR1-TFE3 (alveolar soft part sarcoma), ETV6-NTRK3 (congenital fibrosarcoma), Transcript (endometrial stromal sarcoma), JAZF1/SUZ12 (endometrial stromal sarcoma), YWHAE-FAM22 (endometrial stromal sarcoma), YWHAE-NUTM22A/B (endometrial stromal sarcoma), PAX-MAML3 (sinonasal sarcoma) , PAX3-NCOA1 (sinonasal sarcoma), MYH9-USP6 (fasciitis), EWSR1-ETAF1, EWSR1-PATZ1, CLTC-ALK, hSNF5/INI1 (malignant rhabdoid tumors), EWSR1-CREB3L2, NAB2-STAT6, SRF-NCOA1, FUS/FEV, EWS/NFATc2

Non interpretable transcript (RT-PCR)

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

FISH

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description : FISH performed

Possible values :
No, Yes

Positive (FISH)

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
EWSR1 (BA), SSI8 (BA), FOXOA1 (BA), FUS (BA), DDIT3 (BA), ETV6 (BA), PDGFB (BA), COL1A1- PDGFB (fusion), CIC (BA), USP6 (BA), PHF1 (BA), TFE3 (BA), YWHAE (BA), JAZF1 (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-FLI1, EWSR1-ERG, WWTR1 (BA), CKN2A (P16), CAMTA1 (BA), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEAS, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB

Negative (FISH)

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
EWSR1 (BA), SSI8 (BA), FOXOA1 (BA), FUS (BA), DDIT3 (BA), ETV6 (BA), PDGFB (BA), COL1A1- PDGFB (fusion), CIC (BA), JAZF1 (BA), USP6 (BA), PHF1 (BA), TFE3 (BA), YWHAE (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-ERG, EWSR1-FLI1, WWTR1 (BA), CKN2A (P16), CAMTA1 (BA), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEAS, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB, HMGA2

Non interpretable (FISH)

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
CIC (BA), COL1A1- PDGFB (fusion), DDIT3 (BA), ETV6 (BA), EWSR1 (BA), FOXOA1 (BA), FUS (BA), PDGFB (BA), PHF1 (BA), JAZF1 (BA), SSI8 (BA), TFE3 (BA), USP6 (BA), YWHAE (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-FLI1, EWSR1-ERG, WWTR1 (BA), CAMTA1 (BA), CKN2A (P16), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEAS, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB

GenesMut

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
APC, BRAF, CTNNB1, GNAS, H3F3A, H3F3B, INI1, KIT, MYOD1, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD, SMARCA4, SMARCB1, TP53, Other

OtherGenesMut

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

APC status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Mutation, No mutation, Non amplifiable DNA

TypeTechAPC

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

BRAF status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
V600E, Other, No mutation, Non amplifiable DNA

TypeTechBRAF

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

Exon 3 status (CTNNB1)

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
41A mutation, 45F mutation, 45P mutation, Other mutation, No mutation, Non amplifiable DNA

TypeTechCTNNB1

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

H3F3A status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Mutation, No mutation, No amplifiable DNA

TypeTechH3F3A

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

H3F3B status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Mutation, No mutation, No amplifiable DNA

TypeTechH3F3B

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

INI1 status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Mutation, No mutation, Non amplifiable DNA

TypeTechINI1

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

KIT status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
Exon9, Exon11, Exon13, Exon17, Other exon, No mutation, No amplifiable DNA

TypeTechKIT

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

KIT Nucleotidic formula exon 9

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

KIT Proteic formula exon 9

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

KIT Nucleotidic formula exon 11

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

KIT Proteic formula exon 11

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

KIT Nucleotidic formula exon 13

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

KIT Proteic formula exon 13

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

KIT Nucleotidic formula exon 17

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

KIT Proteic formula exon 17

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

MYOD1 status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Mutation, No mutation, No amplifiable DNA

TypeTechMYOD1

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

NF1 status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Mutation, No mutation, No amplifiable DNA

TypeTechNF1

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

PDGFRA status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
Exon12, Exon14, Exon18, Other exon, No mutation, No amplifiable DNA

TypeTechPDGFRA

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

PDGFRA Nucleotidic formula exon 12

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

PDGFRA Proteic formula exon 12

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

PDGFRA Nucleotidic formula exon 14

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

PDGFRA Proteic formula exon 14

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

PDGFRA Nucleotidic formula exon 18

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

PDGFRA Proteic formula exon 18

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

SDHA status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Mutation, No mutation, No amplifiable DNA

TypeTechSDHA

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

SDHB status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Mutation, No mutation, No amplifiable DNA

TypeTechSDHB

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

SDHC status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Mutation, No mutation, No amplifiable DNA

TypeTechSDHC

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

SDHD status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Mutation, No mutation, No amplifiable DNA

TypeTechSDHD

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

SMARCA4 status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Mutation, No mutation, No amplifiable DNA

TypeTechSMARCA4

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

SMARCB1 status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Mutation, No mutation, No amplifiable DNA

TypeTechSMARCB1

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
DHPLC, Sequencing, Both, Other

P53 mutation status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Mutation, No mutation, Non amplifiable DNA

TypeTechTP53

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Sequencing, Functional assay, Both, Other

P53 nucleotidic formula 1

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

P53 proteic formula 1

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

P53 nucleotidic formula 2

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

P53 proteic formula 2

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Amplification analysis

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Yes, No

GenesAmp

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No

Description :

Possible values :
CDK4, CMYC, MDM2, Other

OtherGenesAmp

Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Result CDK4

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Negative, Positive, Non interpretable

TypeTechCDK4

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
FISH, Q-PCR, Array-CGH, Other

ResultCMYC

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Negative, Positive, Non interpretable

TypeTechCMYC

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
FISH, Q-PCR, Array-CGH, Other

Result MDM2

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Negative, Positive, Non interpretable

TypeTechMDM2

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
FISH, Q-PCR, Array-CGH, Other

P53 polymorphism

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
Yes, No

P53 functional status

Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No

Description :

Possible values :
WT, Mut